Tobramycin Solution
Product Images NDC 76204-029
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Tobramycin (NDC 76204-029). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ritedose Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Figure 1)
This text provides information on the relative change from baseline in FEV % predicted for two studies involving Tobramycin Inhalation Solution and Placebo. Study 1 for Tobramycin Inhalation Solution had 100 participants, while Study 2 had 149 participants. Study 1 for Placebo had 114 participants, and Study 2 had 148 participants. The data also includes numerical values for the change in FEV % predicted.*
Figure 2 (Figure 2)
Structural Formula For Tobramycin (Tob00 0015 01)
Figure A (Tob00 0015 04)
Figure B (Tob00 0015 05)
Figure C (Tob00 0015 06)
Figure D (Tob00 0015 07)
Figure E (Tob00 0015 08)
Figure F (Tob00 0015 09)
Figure G (Tob00 0015 10)
Figure H (Tob00 0015 11)
Figure I (Tob00 0015 12)
Figure J (Tob00 0015 13)
Figure K (Tob00 0015 14)
Figure L (Tob00 0015 15)
Figure M (Tob00 0015 16)
Figure N (Tob00 0015 17)
Figure O (Tob00 0015 18)
Figure P (Tob00 0015 19)
Figure Q (Tob00 0015 20)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.